C

Celltrion Pharm Inc
KOSDAQ:068760

Watchlist Manager
Celltrion Pharm Inc
KOSDAQ:068760
Watchlist
Price: 53 000 KRW 0.76% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
Celltrion Pharm Inc?
Write Note

Gross Margin
Celltrion Pharm Inc

26.1%
Current
29%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
26.1%
=
Gross Profit
114.3B
/
Revenue
437.4B

Gross Margin Across Competitors

Country KR
Market Cap 2.2T KRW
Gross Margin
26%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 744.2B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 373.9B USD
Gross Margin
69%
Country US
Market Cap 258.4B USD
Gross Margin
77%
Country CH
Market Cap 200.6B CHF
Gross Margin
73%
Country UK
Market Cap 161.8B GBP
Gross Margin
82%
Country CH
Market Cap 180.7B CHF
Gross Margin
75%
Country US
Market Cap 146.9B USD
Gross Margin
71%
No Stocks Found

Celltrion Pharm Inc
Glance View

Market Cap
2.2T KRW
Industry
Pharmaceuticals

Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 841 full-time employees. The company went IPO on 2006-02-03. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. The company also provides ethical drugs and over-the-counter (OTC) drugs. The firm distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.

Intrinsic Value
17 592.39 KRW
Overvaluation 67%
Intrinsic Value
Price
C

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
26.1%
=
Gross Profit
114.3B
/
Revenue
437.4B
What is the Gross Margin of Celltrion Pharm Inc?

Based on Celltrion Pharm Inc's most recent financial statements, the company has Gross Margin of 26.1%.